Members |
targetComponentId |
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Tobramycin 1.2g powder for injection solution vial |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Tobramycin 1.2mg/mL injection |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Tobramycin 300mg/5mL nebulizer solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Tobramycin 60mg/mL solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Tocilizumab 20mg/mL conventional release solution for injection |
Tocilizumab only product in parenteral dose form |
Tocilizumab 20mg/mL solution for intravenous infusion |
Tocilizumab only product in parenteral dose form |
Tocopherol |
Vitamin E and/or vitamin E derivative (substance) |
Toe X-ray |
Plain X-ray of toe (procedure) |
Toe X-ray |
Plain X-ray of toe (procedure) |
Toe X-ray |
Plain X-ray of toe (procedure) |
Toe flap |
Flap (substance) |
Tolnaftate+chlorhexidine hydrochloride |
Product containing chlorhexidine and tolnaftate (medicinal product) |
Tolterodine 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg prolonged-release oral capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 2mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 2mg prolonged-release oral capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
Toluene diisocyanate specific extract |
Toluene-2-4-diisocyanate |
Tomato - dietary |
Tomato (substance) |
Tomilol |
Timolol (substance) |
Tomography - NOS |
Tomographic imaging procedure (procedure) |
Tomography - NOS |
Tomographic imaging procedure (procedure) |
Tongue diseases NOS |
Disorder of tongue (disorder) |
Tongue diseases NOS |
Disorder of tongue (disorder) |
Tongue flap |
Flap (substance) |
Tonic-clonic epilepsy |
Epilepsy |
Tonsil (& peritonsillar region) |
Palatine tonsillar structure |
Tonsil/adenoid operation NOS |
Operations on tonsil and adenoid |
Tonsil/adenoid operation NOS |
Operations on tonsil and adenoid |
Tooth and gingiva operations NOS |
Tooth and gingiva operations |
Tooth and gingiva operations NOS |
Tooth and gingiva operations |
Tooth attrition |
Excessive attrition of teeth |
Tooth decalcification |
Incipient enamel caries |
Tooth eruption disturbances NOS |
Tooth eruption disorder (disorder) |
Tooth removal NOS |
Tooth extraction |
Tooth removal NOS |
Tooth extraction |
Tooth restoration NOS |
Restoration of tooth (procedure) |
Tooth restoration NOS |
Restoration of tooth (procedure) |
Tooth symptom NOS |
Tooth symptoms |
Tooth symptom NOS |
Tooth symptoms |
Top manager - business NOS |
Top manager - business |
Top manager - business NOS |
Top manager - business |
Topical anesthesia for procedure on eye |
Administration of anesthesia (procedure) |
Topical anesthetic |
Local anesthetic (substance) |
Topical compound dexamethasone preparation allergy |
Allergy to dexamethasone |
Topical compound hydrocortisone preparation allergy |
Allergy to hydrocortisone (finding) |
Topical corticosteroid, group I |
Glucocorticoid (substance) |
Topical corticosteroid, group II |
Glucocorticoid (substance) |
Topical corticosteroid, group III |
Glucocorticoid (substance) |
Topical corticosteroid, group IV |
Glucocorticoid (substance) |
Topical corticosteroid, group V |
Glucocorticoid (substance) |
Topical corticosteroid, group VI |
Glucocorticoid (substance) |
Topical dermatological preparation adverse reaction |
Adverse reaction to drug |
Topical dexamethasone allergy |
Allergy to dexamethasone |
Topical estradiol allergy |
Allergy to estradiol (finding) |
Topical hydrocortisone allergy |
Allergy to hydrocortisone (finding) |
Topical prednisolone allergy |
Allergy to prednisolone |
Topical salicylic acid allergy |
Allergy to salicylic acid (finding) |
Topical selenium |
Selenium |
Topical sulfur |
Sulfur |
Topotecan 1mg powder for infusion solution vial |
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
Torday's elephant shrew |
Family Macroscelididae |
Torek operation for orchiopexy |
Orchidopexy |
Torsemide 10mg/mL injection solution ampule |
Product containing only torasemide in parenteral dose form (medicinal product form) |
Torulopsis |
Candida |
Torulopsis candida |
Candida saitoana |
Torulopsis glabrata |
Nakaseomyces glabratus (organism) |
Torulopsis pintolopesii |
Candida pintolopesii |
Total biopterins |
Substance with biopterin structure (substance) |
Total colectomy, ileostomy and creation of rectal fistula however further qualified |
Total colectomy, ileostomy and rectal mucous fistula |
Total estimated daily energy intake |
Estimated quantity of intake of energy in 24 hours (observable entity) |
Total excision of bladder NOS |
Complete cystectomy |
Total excision of bladder NOS |
Complete cystectomy |
Total excision of organ NOC |
Complete excision of organ (procedure) |
Total excision of stomach NOS |
Total gastrectomy |
Total excision of stomach NOS |
Total gastrectomy |
Total prosthetic replacement of hip joint not using cement NOS |
Uncemented prosthetic total arthroplasty of hip joint |
Total prosthetic replacement of hip joint using cement NOS |
Cemented prosthetic total arthroplasty of hip joint (procedure) |
Total white cell count NOS |
White blood cell count |
Total white cell count NOS |
White blood cell count |
Tourette's disorder |
Gilles de la Tourette's syndrome |
Town planner/architect NOS |
Architect AND/OR town planner |
Town planner/architect NOS |
Architect AND/OR town planner |
Toxemia of pregnancy |
Pre-eclampsia (disorder) |
Toxic effect |
Poisoning |
Toxic effect from eating shellfish |
Toxic effect from eating shellfish (disorder) |
Toxic effect from noxious substance eaten as food, NEC |
Food poisoning |
Toxic effect of chiefly nonmedicinal substance, NEC |
Toxic effect of chiefly nonmedicinal substance |
Toxic effect of hydrocarbon gas, NEC |
Toxic effect of hydrocarbon gas |
Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues |
Poisoning caused by substance with benzene structure (disorder) |
Toxic effect of non-petroleum-based solvent |
Toxic effect of nonpetroleum-based solvent |
Toxic effect of noxious substance eaten as food |
Food poisoning |
Toxic effect of other nonpetroleum-based solvent, NEC |
Toxic effect of nonpetroleum-based solvent |
Toxic effect of tobacco and nicotine |
Nicotine poisoning |
Toxic effects - substances NOS |
Poisoning |
Toxic effects - substances NOS |
Poisoning |
Toxic encephalopathy |
Toxic encephalopathy |
Toxic liver disease with acute hepatitis |
Acute toxic hepatitis |